Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 106, Issue 2, Pages E680-E686Publisher
ENDOCRINE SOC
DOI: 10.1210/clinem/dgaa875
Keywords
congenital adrenal hyperplasia; 21-hydroxylase; salt-wasting; genetics
Categories
Ask authors/readers for more resources
This case of salt-losing 21-hydroxylase deficiency is homozygous for two mild pathogenic variants: V281L and S301Y. Co-occurrence of these mutations severely impairs the function of the 21-hydroxylase enzyme, which has important implications for genetic counseling. Consideration of these mild variants as having mild phenotypic effects may lead to inappropriate counseling of heterozygote carriers.
Context Congenital adrenal hyperplasia due to 21-hydroxylase deficiency presents with different severities that correlate with the genotype. The salt-losing phenotype requires 2 alleles with severe mutations. Case Description We present a case of salt-losing 21-hydroxylase deficiency that was found to be homozygous for 2 mild pathogenic variants: V281L and S301Y. Both in silico and heterologous expression functional analysis demonstrated that co-occurrence of these 2 mutations in cis severely impairs the function of the 21-hydroxylase enzyme. Conclusions This case has important implications for genetic counseling. Regarding this combination of 2 mild variants as having mild phenotypic effects could lead to inappropriate counseling of heterozygote carriers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available